Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Franco-Nevada
FNV
$46B
| $5.72M | ﹤0.01% |
62,786
+30,818
| +96% | +$2.83M |
|
1727
PUT
General Dynamics
GD
$106B
| $5.72M | ﹤0.01% |
31,300
+3,100
| +11% | +$576K |
|
1728
Hain Celestial
HAIN
$53.7M
| $5.72M | ﹤0.01% |
266,258
-139,916
| -34% | -$2.93M |
|
1729
Teledyne Technologies
TDY
$32B
| $5.71M | ﹤0.01% |
17,755
-2,516
| -12% | -$751K |
|
1730
Rithm Capital
RITM
$5.69B
| $5.71M | ﹤0.01% |
364,297
-858,322
| -70% | -$12.8M |
|
|
RDS.A
1731
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.71M | ﹤0.01% |
97,000
+23,600
| +32% | +$1.4M |
|
|
SCHW
1732
PUT
Charles Schwab
SCHW
$187B
| $5.7M | ﹤0.01% |
136,300
-212,700
| -61% | -$8.58M |
|
1733
W.P. Carey
WPC
$16.4B
| $5.69M | ﹤0.01% |
64,950
-41,237
| -39% | -$3.51M |
|
|
KYNB
1734
Kyntra Bio
KYNB
$29.4M
| $5.69M | ﹤0.01% |
6,157
-80
| -1% | -$87.9K |
|
1735
Coherent
COHR
$74.2B
| $5.69M | ﹤0.01% |
161,503
+85,669
| +113% | +$3.27M |
|
|
PRAH
1736
DELISTED
PRA Health Sciences, Inc.
PRAH
| $5.68M | ﹤0.01% |
57,285
-5,014
| -8% | -$498K |
|
|
BDN
1737
Brandywine Realty Trust
BDN
$554M
| $5.67M | ﹤0.01% |
374,578
+83,676
| +29% | +$1.22M |
|
|
AXON
1738
PUT
Axon Enterprise
AXON
$46.4B
| $5.67M | ﹤0.01% |
99,900
+52,900
| +113% | +$3.34M |
|
|
SNV
1739
DELISTED
Synovus
SNV
| $5.66M | ﹤0.01% |
158,151
+7,089
| +5% | +$254K |
|
|
HTT
1740
High Templar Tech Ltd
HTT
$391M
| $5.66M | ﹤0.01% |
820,639
+360,510
| +78% | +$2.9M |
|
1741
Credit Acceptance
CACC
$6.08B
| $5.65M | ﹤0.01% |
12,249
+1,776
| +17% | +$839K |
|
1742
Hexcel
HXL
$7.82B
| $5.65M | ﹤0.01% |
68,746
+45,918
| +201% | +$3.75M |
|
1743
Gildan
GIL
$10.6B
| $5.63M | ﹤0.01% |
158,691
-3,157
| -2% | -$119K |
|
1744
KB Home
KBH
$3.59B
| $5.63M | ﹤0.01% |
165,545
+1,926
| +1% | +$53.9K |
|
|
PPL
1745
CALL
PPL Corp
PPL
$26.7B
| $5.6M | ﹤0.01% |
177,900
+3,000
| +2% | +$90.7K |
|
1746
CALL
CME Group
CME
$94.8B
| $5.6M | ﹤0.01% |
26,500
+600
| +2% | +$125K |
|
|
1747
PUT
CME Group
CME
$94.8B
| $5.6M | ﹤0.01% |
26,500
+17,400
| +191% | +$3.64M |
|
|
AAT
1748
American Assets Trust
AAT
$1.4B
| $5.58M | ﹤0.01% |
119,450
-2,753
| -2% | -$129K |
|
|
XENT
1749
DELISTED
Intersect ENT, Inc
XENT
| $5.58M | ﹤0.01% |
327,818
+134,280
| +69% | +$2.44M |
|
1750
CALL
TotalEnergies
TTE
$190B
| $5.57M | ﹤0.01% |
107,100
-15,800
| -13% | -$819K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.